Newsfile Corp
12 Jun 2026, 21:39 UTC · 2h ago
PreveCeutical Closes Second Tranche of Non-Brokered Private Placement
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Newsfile Corp
12 Jun 2026, 21:39 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
PreveCeutical closed a second tranche of its private placement, raising $245,000 via the issuance of 9.8 million units at $0.025 per unit. — The issuance of a large volume of shares at a very low price point typically causes immediate dilution for existing shareholders.
-0.30The company intends to close further tranches of the offering within the next four weeks. — Signals further upcoming share dilution and a continuing need for emergency capital.
-0.20Aggregate proceeds from the first and second tranches ($585,000) are designated for paying outstanding payables, operating expenses, and general working capital. — Using capital raises to fund basic operations and debt rather than growth or R&D suggests financial instability.
-0.10Which stocks this story touches
Continue reading
6 related stories
Top 1 mover · tap to explore
The company successfully closed a second tranche of a private placement, raising additional working capital.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Newsfile Corp
4h ago
